Patent holdings for IPC class A61K 31/553

Total number of patents in this class: 2332

10-year publication summary

122
110
135
110
131
125
140
233
245
10
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Genentech, Inc.
4014
84
Gilead Sciences, Inc.
2113
80
Amgen Inc.
4275
49
AstraZeneca AB
2835
41
F. Hoffmann-La Roche AG
7896
39
Rigel Pharmaceuticals, Inc.
528
38
Takeda Pharmaceutical Company Limited
2707
37
Boehringer Ingelheim International GmbH
4591
35
Merck Sharp & Dohme LLC
3737
32
Novartis AG
10506
31
Bristol-myers Squibb Company
4793
29
Eli Lilly and Company
3949
23
Insmed Incorporated
250
23
VALO Health, Inc.
181
22
Janssen Pharmaceutica N.V.
3345
21
Glaxosmithkline Intellectual Property Development Limited
775
21
Daiichi Sankyo Company, Limited
1877
21
The Trustees of Columbia University in the City of New York
3599
20
Vertex Pharmaceuticals Incorporated
1629
18
Taisho Pharmaceutical Co., Ltd.
867
17
Other owners 1651